se of Herbal Medicine likeTulasi,Amruth(Giloy), Turmeric,Ashwagandha as add on treatment in COVID-19 Patients
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2020/06/025592
- Lead Sponsor
- Sri Sri Tattva
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Confirmed Asymptomatic and mildly symptomatic cases of COVID-19 infection by laboratory tests
Age limit 18 to 60 years both Male and Female
Uncomplicated cases of COVID - 19 patients on Allopathic medication
Patients in whom ventilator support is not required
Patients with no associated co morbidities
Patients willing to give informed consent to participate in the clinical trial
COVID-19 positive patients above 60 years of age & below 18 years with Symptoms.
Patients with associated comorbidities like hypertension, type 2 or type 1 diabetes mellitus, chronic or acute renal failure
Patients on Immuno-suppression therapy
Pregnant Women or lactating mothers Patients in advanced stage of disease requiring emergency medical intervention like pneumonia, bronchial asthma, organ failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Early recovery in the signs and symptoms of cases of Asymptomatic and mild symptomatic COVID-19 patients by adding Ayurvedic medicines which are effective in enhancing immunity of body and reducing the symptoms such as Fever and respiratory distressTimepoint: Day 1 and Day 30
- Secondary Outcome Measures
Name Time Method a. TNF-α <br/ ><br>b. IL-6 <br/ ><br>c. IFN- β <br/ ><br>d. IFN-λTimepoint: Day 1 and Day 30